SPG released its performance for the first three quarters, with a net profit attributable to the parent company of 542 million yuan, a year-on-year decrease of 24.7%

According to the Zhitong Finance APP, Shandong Pharmaceutical Glass disclosed its third-quarter report for 2025. The company achieved revenue of 3.401 billion yuan in the first three quarters, a year-on-year decrease of 11.10%; net profit attributable to the parent company was 542 million yuan, a year-on-year decrease of 24.7%; net profit excluding non-recurring gains and losses was 516 million yuan, a year-on-year decrease of 25.13%; basic earnings per share were 0.8174 yuan